Search

Your search keyword '"bersano, anna"' showing total 589 results
Start Over Author "bersano, anna"
589 results on '"bersano, anna"'

3. Virtual hospital and artificial intelligence: a first step towards the application of an innovative health system for the care of rare cerebrovascular diseases

Author

Rifino, Nicola, Bersano, Anna, Padovani, Alessandro, Conti, Giancarlo Maria, Cavallini, Anna, Colombo, Luca, Priori, Alberto, Pianese, Raffaella, Gammone, Maria Rosaria, Erbetta, Alessandra, Ciceri, Elisa Francesca, Sattin, Davide, Varvello, Riccardo, Parati, Eugenio Agostino, and Scelzo, Emma

Published
2024
Full Text
View/download PDF

4. Susceptibility to brain ischemia and the association between migraine and spontaneous cervical artery dissection

Author

Del Zotto, Elisabetta, Grassi, Mario, Zedde, Marialuisa, Zini, Andrea, Bersano, Anna, Gandolfo, Carlo, Silvestrelli, Giorgio, Baracchini, Claudio, Cerrato, Paolo, Lodigiani, Corrado, Marcheselli, Simona, Paciaroni, Maurizio, Spalloni, Alessandra, Cappellari, Manuel, Del Sette, Massimo, Cavallini, Anna, Lotti, Enrico Maria, DeLodovici, Maria Luisa, Gentile, Mauro, Magoni, Mauro, Padroni, Marina, Azzini, Cristiano, Calloni, Maria Vittoria, Giorli, Elisa, Braga, Massimiliano, La Spina, Paolo, Melis, Fabio, Tassi, Rossana, Terruso, Valeria, Calabrò, Rocco Salvatore, Piras, Valeria, Giossi, Alessia, Sanguigni, Sandro, Zanferrari, Carla, Mannino, Marina, Colombo, Irene, Dallocchio, Carlo, Nencini, Patrizia, Bignamini, Valeria, Adami, Alessandro, Bella, Rita, Pascarella, Rosario, and Pezzini, Alessandro

Published
2023
Full Text
View/download PDF

6. Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative

Author

Sasanejad, Payam, Afshar Hezarkhani, Leila, Arsang-Jang, Shahram, Tsivgoulis, Georgios, Ghoreishi, Abdoreza, Barlinn, Kristian, Rahmig, Jan, Farhoudi, Mehdi, Sadeghi Hokmabadi, Elyar, Borhani-Haghighi, Afshin, Sariaslani, Payam, Sharifi-Razavi, Athena, Ghandehari, Kavian, Khosravi, Alireza, Smith, Craig, Nilanont, Yongchai, Akbari, Yama, Nguyen, Thanh N, Bersano, Anna, Yassi, Nawaf, Yoshimoto, Takeshi, Lattanzi, Simona, Gupta, Animesh, Zand, Ramin, Rafie, Shahram, Pourandokht Mousavian, Seyede, Reza Shahsavaripour, Mohammad, Amini, Shahram, Kamenova, Saltanat U, Kondybayeva, Aida, Zhanuzakov, Murat, Macri, Elizabeth M, Nobleza, Christa O'Hana S, Ruland, Sean, Cervantes-Arslanian, Anna M, Desai, Masoom J, Ranta, Annemarei, Moghadam Ahmadi, Amir, Rostamihosseinkhani, Mahtab, Foroughi, Razieh, Hooshmandi, Etrat, Akhoundi, Fahimeh H, Shuaib, Ashfaq, Liebeskind, David S, Siegler, James, Romano, Jose G, Mayer, Stephan A, Bavarsad Shahripour, Reza, Zamani, Babak, Woolsey, Amadene, Fazli, Yasaman, Mojtaba, Khazaei, Isaac, Christian F, Biller, Jose, Di Napoli, Mario, and Azarpazhooh, M Reza

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Neurosciences, Stroke, Brain Disorders, Clinical Research, Good Health and Well Being, Aged, Aged, 80 and over, COVID-19, Disability Evaluation, Europe, Female, Fibrinolytic Agents, Hospital Mortality, Humans, Infusions, Intravenous, Intracranial Hemorrhages, Iran, Ischemic Stroke, Male, Middle Aged, Risk Assessment, Risk Factors, Thrombolytic Therapy, Time Factors, Treatment Outcome, COVID 19, Thrombolytic therapy, Longitudinal study, Safety, Outcomes, Disability, Stroke severity, death, Neurology & Neurosurgery, Clinical sciences
Abstract

BackgroundThere is little information regarding the safety of intravenous tissue plasminogen activator (IV-tPA) in patients with stroke and COVID-19.MethodsThis multicenter study included consecutive stroke patients with and without COVID-19 treated with IV-tPA between February 18, 2019, to December 31, 2020, at 9 centers participating in the CASCADE initiative. Clinical outcomes included modified Rankin Scale (mRS) at hospital discharge, in-hospital mortality, the rate of hemorrhagic transformation. Using Bayesian multiple regression and after adjusting for variables with significant value in univariable analysis, we reported the posterior adjusted odds ratio (OR, with 95% Credible Intervals [CrI]) of the main outcomes.ResultsA total of 545 stroke patients, including 101 patients with COVID-19 were evaluated. Patients with COVID-19 had a more severe stroke at admission. In the study cohort, 85 (15.9%) patients had a hemorrhagic transformation, and 72 (13.1%) died in the hospital. After adjustment for confounding variables, discharge mRS score ≥2 (OR: 0.73, 95% CrI: 0.16, 3.05), in-hospital mortality (OR: 2.06, 95% CrI: 0.76, 5.53), and hemorrhagic transformation (OR: 1.514, 95% CrI: 0.66, 3.31) were similar in COVID-19 and non COVID-19 patients. High-sensitivity C reactive protein level was a predictor of hemorrhagic transformation in all cases (OR:1.01, 95%CI: 1.0026, 1.018), including those with COVID-19 (OR:1.024, 95%CI:1.002, 1.054).ConclusionIV-tPA treatment in patients with acute ischemic stroke and COVID-19 was not associated with an increased risk of disability, mortality, and hemorrhagic transformation compared to those without COVID-19. IV-tPA should continue to be considered as the standard of care in patients with hyper acute stroke and COVID-19.

Published
2021

7. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE).

Author

Abootalebi, Shahram, Aertker, Benjamin M, Andalibi, Mohammad Sobhan, Asdaghi, Negar, Aykac, Ozlem, Azarpazhooh, M Reza, Bahit, M Cecilia, Barlinn, Kristian, Basri, Hamidon, Shahripour, Reza Bavarsad, Bersano, Anna, Biller, Jose, Borhani-Haghighi, Afshin, Brown, Robert D, Campbell, Bruce Cv, Cruz-Flores, Salvador, De Silva, Deidre Anne, Di Napoli, Mario, Divani, Afshin A, Edgell, Randall C, Fifi, Johanna T, Ghoreishi, Abdoreza, Hirano, Teruyuki, Hong, Keun-Sik, Hsu, Chung Y, Huang, Josephine F, Inoue, Manabu, Jagolino, Amanda L, Kapral, Moira, Kee, Hoo Fan, Keser, Zafer, Khatri, Rakesh, Koga, Masatoshi, Krupinski, Jerzy, Liebeskind, David S, Liu, Liping, Ma, Henry, Maud, Alberto, McCullough, Louise D, Meyer, Dawn Matherne, Mifsud, Victoria, Morovatdar, Negar, Nilanont, Yongchai, Oxley, Thomas J, Özdemir, Atilla Özcan, Pandian, Jeyaraj, Pantoni, Leonardo, Papamitsakis, Nikolaos IH, Parry-Jones, Adrian, Phan, Thanh, Rodriguez, Gustavo, Romano, Jose G, Sabaa-Ayoun, Ziad, Saber, Hamidreza, Sasannezhad, Payam, Saver, Jeffrey L, Scharf, Eugene, Shuaib, Ashfaq, Silver, Brian, Singhal, Shaloo, Smith, Craig J, Stranges, Saverio, Sylaja, PN, Torbey, Michel, Toyoda, Kazunori, Tsivgoulis, Georgios, Wasay, Mohammad, Yassi, Nawaf, Yoshimoto, Takeshi, Zamani, Babak, and Zand, Ramin

Subjects
Humans, Pneumonia, Viral, Coronavirus Infections, Treatment Outcome, Hospitalization, Registries, Incidence, Hospital Mortality, Risk Factors, Retrospective Studies, Prospective Studies, Comorbidity, Time Factors, Stroke, Healthcare Disparities, Host-Pathogen Interactions, Pandemics, Interrupted Time Series Analysis, Practice Patterns, Physicians', Betacoronavirus, COVID-19, SARS-CoV-2, Health policy, Mortality, National crisis, Pandemic, Pneumonia, Viral, Practice Patterns, Physicians', Physicians, Neurology & Neurosurgery, Clinical Sciences, Neurosciences
Abstract

Background and purposeThe novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), now named coronavirus disease 2019 (COVID-19), may change the risk of stroke through an enhanced systemic inflammatory response, hypercoagulable state, and endothelial damage in the cerebrovascular system. Moreover, due to the current pandemic, some countries have prioritized health resources towards COVID-19 management, making it more challenging to appropriately care for other potentially disabling and fatal diseases such as stroke. The aim of this study is to identify and describe changes in stroke epidemiological trends before, during, and after the COVID-19 pandemic.MethodsThis is an international, multicenter, hospital-based study on stroke incidence and outcomes during the COVID-19 pandemic. We will describe patterns in stroke management, stroke hospitalization rate, and stroke severity, subtype (ischemic/hemorrhagic), and outcomes (including in-hospital mortality) in 2020 during COVID-19 pandemic, comparing them with the corresponding data from 2018 and 2019, and subsequently 2021. We will also use an interrupted time series (ITS) analysis to assess the change in stroke hospitalization rates before, during, and after COVID-19, in each participating center.ConclusionThe proposed study will potentially enable us to better understand the changes in stroke care protocols, differential hospitalization rate, and severity of stroke, as it pertains to the COVID-19 pandemic. Ultimately, this will help guide clinical-based policies surrounding COVID-19 and other similar global pandemics to ensure that management of cerebrovascular comorbidity is appropriately prioritized during the global crisis. It will also guide public health guidelines for at-risk populations to reduce risks of complications from such comorbidities.

Published
2020

10. Genetic Risk Score for Intracranial Aneurysms: Prediction of Subarachnoid Hemorrhage and Role in Clinical Heterogeneity

Author

Bakker, Mark K., Kanning, Jos P., Abraham, Gad, Martinsen, Amy E., Winsvold, Bendik S., Zwart, John-Anker, Bourcier, Romain, Sawada, Tomonobu, Koido, Masaru, Kamatani, Yoichiro, Morel, Sandrine, Amouyel, Philippe, Debette, Stéphanie, Bijlenga, Philippe, Berrandou, Takiy, Ganesh, Santhi K., Bouatia-Naji, Nabila, Jones, Gregory, Bown, Matthew, Rinkel, Gabriel J.E., Veldink, Jan H., Ruigrok, Ynte M., Hege Aamodt, Anne, Heidi Skogholt, Anne, Brumpton, Ben M, Willer, Cristen J, Sandset, Else C, Kristoffersen, Espen S, Ellekjær, Hanne, Heuch, Ingrid, Nielsen, Jonas B, Hagen, Knut, Hveem, Kristian, Fritsche, Lars G, Thomas, Laurent F, Pedersen, Linda M, Gabrielsen, Maiken E, Holmen, Oddgeir L, Børte, Sigrid, Zhou, Wei, Abboud, Shérine, Pandolfo, Massimo, Thijs, Vincent, Leys, Didier, Bodenant, Marie, Louillet, Fabien, Touzé, Emmanuel, Mas, Jean-Louis, Samson, Yves, Leder, Sara, Léger, Anne, Deltour, Sandrine, Crozier, Sophie, Méresse, Isabelle, Canaple, Sandrine, Godefroy, Olivier, Giroud, Maurice, Béjot, Yannick, Decavel, Pierre, Medeiros, Elizabeth, Montiel, Paola, Moulin, Thierry, Vuillier, Fabrice, Dallongeville, Jean, Metso, Antti J, Metso, Tiina, Tatlisumak, Turgut, Grond-Ginsbach, Caspar, Lichy, Christoph, Kloss, Manja, Werner, Inge, Arnold, Marie-Luise, Dos Santos, Michael, Grau, Armin, Dichgans, Martin, Thomas-Feles, Constanze, Weber, Ralf, Brandt, Tobias, Pezzini, Alessandro, De Giuli, Valeria, Caria, Filomena, Poli, Loris, Padovani, Alessandro, Bersano, Anna, Lanfranconi, Silvia, Beretta, Simone, Ferrarese, Carlo, Giacolone, Giacomo, Paolucci, Stefano, Lyrer, Philippe, Engelter, Stefan, Fluri, Felix, Hatz, Florian, Gisler, Dominique, Bonati, Leo, Gensicke, Henrik, Amort, Margareth, Markus, Hugh, Majersik, Jennifer, Worrall, Bradford, Southerland, Andrew, Cole, John, Kittner, Steven, Evangelou, Evangelos, Warren, Helen R, Gao, He, Ntritsos, Georgios, Dimou, Niki, Esko, Tonu, Mägi, Reedik, Milani, Lili, Almgren, Peter, Boutin, Thibaud, Ding, Jun, Giulianini, Franco, Holliday, Elizabeth G, Jackson, Anne U, Li-Gao, Ruifang, Lin, Wei-Yu, Luan, Jian’an, Mangino, Massimo, Oldmeadow, Christopher, Peter Prins, Bram, Qian, Yong, Sargurupremraj, Muralidharan, Shah, Nabi, Surendran, Praveen, Thériault, Sébastien, Verweij, Niek, Willems, Sara M, Zhao, Jing-Hua, Connell, John, de Mutsert, Renée, Doney, Alex SF, Farrall, Martin, Menni, Cristina, Morris, Andrew D, Noordam, Raymond, Paré, Guillaume, Poulter, Neil R, Shields, Denis C, Stanton, Alice, Thom, Simon, Abecasis, Gonçalo, Amin, Najaf, Arking, Dan E, Ayers, Kristin L, Barbieri, Caterina M, Batini, Chiara, Bis, Joshua C, Blake, Tineka, Bochud, Murielle, Boehnke, Michael, Boerwinkle, Eric, Boomsma, Dorret I, Bottinger, Erwin P, Braund, Peter S, Brumat, Marco, Campbell, Archie, Campbell, Harry, Chakravarti, Aravinda, Chambers, John C, Chauhan, Ganesh, Ciullo, Marina, Cocca, Massimiliano, Collins, Francis, Cordell, Heather J, Davies, Gail, de Borst, Martin H, de Geus, Eco J, Deary, Ian J, Deelen, Joris, Del Greco M, Fabiola, Yusuf Demirkale, Cumhur, Dörr, Marcus, Ehret, Georg B, Elosua, Roberto, Enroth, Stefan, Mesut Erzurumluoglu, A, Ferreira, Teresa, Frånberg, Mattias, Franco, Oscar H, Gandin, Ilaria, Gasparini, Paolo, Giedraitis, Vilmantas, Gieger, Christian, Girotto, Giorgia, Goel, Anuj, Gow, Alan J, Gudnason, Vilmundur, Guo, Xiuqing, Gyllensten, Ulf, Hamsten, Anders, Harris, Tamara B, Harris, Sarah E, Hartman, Catharina A, Havulinna, Aki S, Hicks, Andrew A, Hofer, Edith, Hofman, Albert, Hottenga, Jouke-Jan, Huffman, Jennifer E, Hwang, Shih-Jen, Ingelsson, Erik, James, Alan, Jansen, Rick, Jarvelin, Marjo-Riitta, Joehanes, Roby, Johansson, Åsa, Johnson, Andrew D, Joshi, Peter K, Jousilahti, Pekka, Wouter Jukema, J, Jula, Antti, Kähönen, Mika, Kathiresan, Sekar, Keavney, Bernard D, Khaw, Kay-Tee, Knekt, Paul, Knight, Joanne, Kolcic, Ivana, Kooner, Jaspal S, Koskinen, Seppo, Kristiansson, Kati, Kutalik, Zoltan, Laan, Maris, Larson, Marty, Launer, Lenore J, Lehne, Benjamin, Lehtimäki, Terho, Liewald, David CM, Lin, Li, Lind, Lars, Lindgren, Cecilia M, Liu, YongMei, Loos, Ruth JF, Lopez, Lorna M, Lu, Yingchang, Lyytikäinen, Leo-Pekka, Mahajan, Anubha, Mamasoula, Chrysovalanto, Marrugat, Jaume, Marten, Jonathan, Milaneschi, Yuri, Morgan, Anna, Morris, Andrew P, Morrison, Alanna C, Munson, Peter J, Nalls, Mike A, Nandakumar, Priyanka, Nelson, Christopher P, Niiranen, Teemu, Nolte, Ilja M, Nutile, Teresa, Oldehinkel, Albertine J, Oostra, Ben A, O’Reilly, Paul F, Org, Elin, Padmanabhan, Sandosh, Palmas, Walter, Palotie, Aarno, Pattie, Alison, WJH Penninx, Brenda, Perola, Markus, Peters, Annette, Polasek, Ozren, Pramstaller, Peter P, Tri Nguyen, Quang, Raitakari, Olli T, Rettig, Rainer, Rice, Kenneth, Ridker, Paul M, Ried, Janina S, Riese, Harriëtte, Ripatti, Samuli, Robino, Antonietta, Rose, Lynda M, Rotter, Jerome I, Rudan, Igor, Ruggiero, Daniela, Saba, Yasaman, Sala, Cinzia F, Salomaa, Veikko, Samani, Nilesh J, Sarin, Antti-Pekka, Schmidt, Reinhold, Schmidt, Helena, Shrine, Nick, Siscovick, David, Smith, Albert V, Snieder, Harold, Sõber, Siim, Sorice, Rossella, Starr, John M, Stott, David J, Strachan, David P, Strawbridge, Rona J, Sundström, Johan, Swertz, Morris A, Taylor, Kent D, Teumer, Alexander, Tobin, Martin D, Tomaszewski, Maciej, Toniolo, Daniela, Traglia, Michela, Trompet, Stella, Tuomilehto, Jaakko, Tzourio, Christophe, Uitterlinden, André G, Vaez, Ahmad, van der Most, Peter J, van Duijn, Cornelia M, Verwoert, Germaine C, Vitart, Veronique, Völker, Uwe, Vollenweider, Peter, Vuckovic, Dragana, Watkins, Hugh, Wild, Sarah H, Willemsen, Gonneke, Wilson, James F, Wright, Alan F, Yao, Jie, Zemunik, Tatijana, Zhang, Weihua, Attia, John R, Butterworth, Adam S, Chasman, Daniel I, Conen, David, Cucca, Francesco, Danesh, John, Hayward, Caroline, Howson, Joanna MM, Laakso, Markku, Lakatta, Edward G, Langenberg, Claudia, Melander, Olle, Mook-Kanamori, Dennis O, Palmer, Colin NA, Risch, Lorenz, Scott, Robert A, Scott, Rodney J, Sever, Peter, Spector, Tim D, van der Harst, Pim, Wareham, Nicholas J, Zeggini, Eleftheria, Levy, Daniel, Munroe, Patricia B, Newton-Cheh, Christopher, Brown, Morris J, Metspalu, Andres, Psaty, Bruce M., Wain, Louise V, Elliott, Paul, Caulfield, Mark J, Gormley, Padhraig, Anttila, Verneri, Palta, Priit, Esko, Tonu, Pers, Tune H, Farh, Kai-How, Cuenca-Leon, Ester, Muona, Mikko, Furlotte, Nicholas A, Kurth, Tobias, Ingason, Andres, McMahon, George, Ligthart, Lannie, Terwindt, Gisela M, Kallela, Mikko, Freilinger, Tobias M, Ran, Caroline, Gordon, Scott G, Stam, Anine H, Steinberg, Stacy, Borck, Guntram, Koiranen, Markku, Quaye, Lydia, Adams, Hieab H H, Lehtimäki, Terho, Sarin, Antti-Pekka, Wedenoja, Juho, Hinds, David A, Buring, Julie E, Schürks, Markus, Ridker, Paul M, Gudlaug Hrafnsdottir, Maria, Stefansson, Hreinn, Ring, Susan M, Hottenga, Jouke-Jan, Penninx, Brenda W J H, Färkkilä, Markus, Artto, Ville, Kaunisto, Mari, Vepsäläinen, Salli, Malik, Rainer, Heath, Andrew C, Madden, Pamela A F, Martin, Nicholas G, Montgomery, Grant W, Kurki, Mitja I, Kals, Mart, Mägi, Reedik, Pärn, Kalle, Hämäläinen, Eija, Huang, Hailiang, Byrnes, Andrea E, Franke, Lude, Huang, Jie, Stergiakouli, Evie, Lee, Phil H, Sandor, Cynthia, Webber, Caleb, Cader, Zameel, Muller-Myhsok, Bertram, Schreiber, Stefan, Meitinger, Thomas, Eriksson, Johan G, Salomaa, Veikko, Heikkilä, Kauko, Loehrer, Elizabeth, Uitterlinden, Andre G, Hofman, Albert, van Duijn, Cornelia M, Cherkas, Lynn, Pedersen, Linda M, Stubhaug, Audun, Nielsen, Christopher S, Männikkö, Minna, Mihailov, Evelin, Milani, Lili, Göbel, Hartmut, Esserlind, Ann-Louise, Francke Christensen, Anne, Folkmann Hansen, Thomas, Werge, Thomas, Kaprio, Jaakko, Aromaa, Arpo J, Raitakari, Olli, Arfan Ikram, M, Spector, Tim, Järvelin, Marjo-Riitta, Metspalu, Andres, Kubisch, Christian, Strachan, David P, Ferrari, Michel D, Belin, Andrea C, Dichgans, Martin, Wessman, Maija, van den Maagdenberg, Arn M J M, Boomsma, Dorret I, Davey Smith, George, Stefansson, Kari, Eriksson, Nicholas, Daly, Mark J, Neale, Benjamin M, Olesen, Jes, Chasman, Daniel I, Nyholt, Dale R, Palotie, Aarno, Akiyama, Masato, Alg, Varinder S., Børte, Sigrid, Broderick, Joseph P., Brumpton, Ben M., Dauvillier, Jérôme, Desal, Hubert, Dina, Christian, Friedrich, Christoph M., Gaál-Paavola, Emília I., Gentric, Jean-Christophe, Hirsch, Sven, Hostettler, Isabel C., Houlden, Henry, Hveem, Kristian, Jääskeläinen, Juha E., Johnsen, Marianne Bakke, Li, Liming, Lin, Kuang, Lindgren, Antti, Martin, Olivier, Matsuda, Koichi, Millwood, Iona Y., Naggara, Olivier, Niemelä, Mika, Pera, Joanna, Redon, Richard, Rouleau, Guy A., Sandvei, Marie Søfteland, Schilling, Sabine, Shotar, Eimad, Slowik, Agnieszka, Terao, Chikashi, Verschuren, W. M. Monique, Walters, Robin G., Werring, David J., Willer, Cristen J., Woo, Daniel, Worrall, Bradford B., and Zhou, Sirui

Published
2023
Full Text
View/download PDF

11. Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASIL

Author

Gravesteijn, Gido, Rutten, Julie W., Cerfontaine, Minne N., Hack, Remco J., Liao, Yi-Chu, Jolly, Amy A., Guey, Stéphanie, Hsu, Shao-Lun, Park, Jae-young, Yuan, Yun, Kopczak, Anna, Rifino, Nicola, Neilson, Sam J., Poggesi, Anna, Shourav, Md Manjurul Islam, Saito, Satoshi, Ishiyama, Hiroyuki, Domínguez Mayoral, Ana, Nogueira, Renata, Muiño, Elena, Andersen, Pia, De Stefano, Nicola, Santo, Gustavo, Sukhonpanich, Nontapat, Mele, Francesco, Park, Ashley, Lee, Jung Seok, Rodríguez-Girondo, Mar, Vonk, Sebastiaan J. J., Brodtmann, Amy, Börjesson-Hanson, Anne, Pantoni, Leonardo, Fernández-Cadenas, Israel, Silva, Ana Rita, Montanaro, Vinícus V. A., Kalaria, Rajesh N., Lopergolo, Diego, Ihara, Masafumi, Meschia, James F., Muir, Keith W., Bersano, Anna, Pescini, Francesca, Duering, Marco, Choi, Jay Chol, Ling, Chen, Kim, Hyunjin, Markus, Hugh S., Chabriat, Hugues, Lee, Yi-Chung, and Lesnik Oberstein, Saskia A. J.

Abstract

IMPORTANCE: Typical cysteine-altering NOTCH3 (NOTCH3cys) variants are highly prevalent (approximately 1 in 300 individuals) and are associated with a broad spectrum of small vessel disease (SVD), ranging from early-onset stroke and dementia (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL]) to nonpenetrance. A staging system that captures the full NOTCH3-SVD severity spectrum is needed and currently lacking. OBJECTIVE: To design a simple disease severity staging system that captures the broad clinicoradiological NOTCH3-SVD severity spectrum. DESIGN, SETTING, AND PARTICIPANTS: A cohort study was performed in which the NOTCH3-SVD severity staging system was developed using a discovery cohort (2019-2020) and validated in independent international CADASIL cohorts (1999-2023) and the UK Biobank. Clinical and imaging data were collected from participants originating from 23 international CADASIL cohorts and from the UK Biobank. Eligibility criteria were presence of a NOTCH3cys variant, availability of brain magnetic resonance imaging, and modified Rankin Scale score. The discovery cohort consisted of 195 NOTCH3cys-positive cases from families with CADASIL; the validation set included 1713 NOTCH3cys-positive cases from 15 countries. The UK Biobank cohort consisted of 101 NOTCH3cys-positive individuals. Data from 2-year (2019-2023) and 18-year (1999-2017) follow-up studies were also analyzed. Data analysis was performed from July 2023 to August 2024. MAIN OUTCOMES AND MEASURES: Percentage of cases following the sequence of events of the NOTCH3-SVD stages, and the association between the stages and ischemic stroke, intracerebral hemorrhage, global cognition, processing speed, brain volume, brain microstructural damage, and serum neurofilament light chain (NfL) level. RESULTS: The NOTCH3-SVD staging system encompasses 9 disease stages or substages, ranging from stage 0 (premanifest stage) to stage 4B (end stage). Of all 1908 cases, which included 195 in the discovery cohort (mean [SD] age, 52.4 [12.2] years) and 1713 in the validation cohorts (mean [SD] age, 53.1 [13.0] years), 1789 (94%) followed the sequence of events defined by the NOTCH3-SVD staging system. The NOTCH3-SVD stages were associated with neuroimaging outcomes in the NOTCH3cys-positive cases in the CADASIL cohorts and in the UK Biobank and with cognitive outcomes and serum NfL level in cases from the CADASIL cohorts. The NOTCH3-SVD staging system captured disease progression and was associated with 18-year survival. CONCLUSIONS AND RELEVANCE: The NOTCH3-SVD staging system captures the full disease spectrum, from asymptomatic individuals with a NOTCH3cys variant to patients with end-stage disease. The NOTCH3-SVD staging system is a simple but effective tool for uniform disease staging in the clinic and in research.

Published
2025
Full Text
View/download PDF

12. Visual fixation in disorders of consciousness: Development of predictive models to support differential diagnosis

Author

Sattin, Davide, Rossi Sebastiano, Davide, Magnani, Francesca Giulia, D'Incerti, Ludovico, Marotta, Giorgio, Benti, Riccardo, Tirelli, Simone, Bersano, Anna, Duran, Dunja, Visani, Elisa, Ferraro, Stefania, Minati, Ludovico, Nigri, Anna, Rosazza, Cristina, Bianchi Marzoli, Stefania, Ciasca, Paola, Carcagni, Antonella, Bruzzone, Maria Grazia, Franceschetti, Silvana, Leonardi, Matilde, and Guido, Davide

Published
2021
Full Text
View/download PDF

17. Expanding the Neurological Phenotype of Anderson–Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism.

Author

Zedde, Marialuisa, Romani, Ilaria, Scaravilli, Alessandra, Cocozza, Sirio, Trojano, Luigi, Ragno, Michele, Rifino, Nicola, Bersano, Anna, Gerevini, Simonetta, Pantoni, Leonardo, Valzania, Franco, and Pascarella, Rosario

Subjects
PARKINSON'S disease, PERIPHERAL nervous system, CEREBROVASCULAR disease, CENTRAL nervous system, STROKE
Abstract

Anderson–Fabry disease (AFD) is a genetic sphingolipidosis involving virtually the entire body. Among its manifestation, the involvement of the central and peripheral nervous system is frequent. In recent decades, it has become evident that, besides cerebrovascular damage, a pure neuronal phenotype of AFD exists in the central nervous system, which is supported by clinical, pathological, and neuroimaging data. This neurodegenerative phenotype is often clinically characterized by an extrapyramidal component similar to the one seen in prodromal Parkinson's disease (PD). We analyzed the biological, clinical pathological, and neuroimaging data supporting this phenotype recently proposed in the literature. Moreover, we compared the neurodegenerative PD phenotype of AFD with a classical monogenic vascular disease responsible for vascular parkinsonism and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). A substantial difference in the clinical and neuroimaging features of neurodegenerative and vascular parkinsonism phenotypes emerged, with AFD being potentially responsible for both forms of the extrapyramidal involvement, and CADASIL mainly associated with the vascular subtype. The available studies share some limitations regarding both patients' information and neurological and genetic investigations. Further studies are needed to clarify the potential association between AFD and extrapyramidal manifestations. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. Angiopoietin‐2 associates with poor prognosis in Moyamoya angiopathy.

Author

Gorla, Gemma, Potenza, Antonella, Carrozzini, Tatiana, Pollaci, Giuliana, Acerbi, Francesco, Vetrano, Ignazio G., Ferroli, Paolo, Canavero, Isabella, Rifino, Nicola, Bersano, Anna, and Gatti, Laura

Subjects
ANGIOPOIETIN-2, RNA interference, SMALL interfering RNA, VASCULAR endothelial growth factors, CAROTID artery
Abstract

Objective: Moyamoya angiopathy (MA) is a rare cerebrovascular disorder characterized by recurrent ischemic/hemorrhagic strokes due to progressive occlusion of the intracranial carotid arteries. The lack of reliable disease severity biomarkers led us to investigate molecular features of a Caucasian cohort of MA patients. Methods: The participants consisted of 30 MA patients and 40 controls. We measured cerebrospinal fluid (CSF) levels of angiogenic/inflammatory factors (ELISA). We then applied quantitative real‐time PCR on cerebral artery specimens for expression analyses of angiogenic factors. By an immunoassay based on microfluidic technology, we examined the potential correlations between plasma protein expression and MA clinical progression. A RNA interference approach toward Ring Finger Protein 213 (RNF213) and a tube formation assay were applied in cellular model. Results: We detected a statistically significant (p < 0.000001) up‐regulation of Angiopoietin‐2 (Ang‐2) in CSF and stenotic middle cerebral arteries (RQ >2) of MA patients compared to controls. A high Ang‐2 plasma concentration (p = 0.018) was associated with unfavorable outcome in a subset of MA patients. ROC curve analyses indicated Ang‐2 as diagnostic CSF biomarker (>3741 pg/mL) and prognostic plasma biomarker (>1162 pg/mL), to distinguish stable‐from‐progressive MA. Consistently, MA cellular model showed a significant up‐regulation (RQ >2) of Ang‐2 in RNF213 silenced condition. Interpretation: Our results pointed out Ang‐2 as a reliable biomarker mirroring arterial steno‐occlusion and vascular instability of MA in CSF and blood, providing a candidate factor for patient stratification. This pilot study may pave the way to the validation of a biomarker to identify progressive MA patients deserving a specific treatment path. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

19. Cognitive and psychological assessment in patients with cerebral amyloid angiopathy

Author

Leonardi, Matilde, primary, Camarda, Giorgia, additional, Mazzucchelli, Alessia, additional, Schiavolin, Silvia, additional, Sismondo, Pietro, additional, Barbadoro, Filippo, additional, Ippoliti, Camilla, additional, Cacciatore, Martina, additional, Marcassoli, Alessia, additional, Bersano, Anna, additional, Canavero, Isabella, additional, and Storti, Benedetta, additional

Published
2023
Full Text
View/download PDF

22. Iatrogenic cerebral amyloid angiopathy: A multinational case series and individual patient data analysis of the literature

Author

Pikija, Slaven, primary, Pretnar-Oblak, Janja, additional, Frol, Senta, additional, Malojcic, Branko, additional, Gattringer, Thomas, additional, Rak-Frattner, Kinga, additional, Staykov, Dimitre, additional, Salmaggi, Andrea, additional, Milani, Riccardo, additional, Magdic, Jozef, additional, Iglseder, Sarah, additional, Trinka, Eugen, additional, Kraus, Theo, additional, Toma, Andreea, additional, DiFrancesco, Jacopo C., additional, Tabaee Damavandi, Payam, additional, Fabin, Natalia, additional, Bersano, Anna, additional, Albajar, Inés, additional, de la Riva, Patricia, additional, Storti, Benedetta, additional, and Fandler-Höfler, Simon, additional

Published
2023
Full Text
View/download PDF

24. Multi‐omic approaches for biomarker discovery in Moyamoya disease.

Author

Gatti, Laura, Bersano, Anna, Gorla, Gemma, Pollaci, Giuliana, Carrozzini, Tatiana, and Potenza, Antonella

Subjects
*MOYAMOYA disease, *BIOMARKERS, *INTERNAL carotid artery
Abstract

Moyamoya disease (MMD) is a rare cerebrovascular condition characterized by the narrowing of the internal carotid arteries, leading to the formation of abnormal blood vessels in the brain. Surgical treatment is currently the preferred option for MMD patients, but the underlying mechanisms of the disease are not well understood. Previous studies have focused on biomarker discovery using peripheral blood samples, but more recent research has explored molecular profiling of circulating biomarkers in cerebrospinal fluid and blood. These studies have identified potential biomarkers and provided insights into the pathogenesis of MMD. Multi-omic approaches, including genomics, transcriptomics, proteomics, and metabolomics, have the potential to improve disease diagnosis, risk stratification, and personalized treatment for MMD patients. [Extracted from the article]

Published
2024
Full Text
View/download PDF

25. Iatrogenic cerebral amyloid angiopathy: A multinational case series and individual patient data analysis of the literature.

Author

Pikija, Slaven, Pretnar-Oblak, Janja, Frol, Senta, Malojcic, Branko, Gattringer, Thomas, Rak-Frattner, Kinga, Staykov, Dimitre, Salmaggi, Andrea, Milani, Riccardo, Magdic, Jozef, Iglseder, Sarah, Trinka, Eugen, Kraus, Theo, Toma, Andreea, DiFrancesco, Jacopo C., Tabaee Damavandi, Payam, Fabin, Natalia, Bersano, Anna, de la Riva Juez, Patricia, and Albajar Gomez, Ines

Subjects
CEREBRAL amyloid angiopathy, PRION diseases, DATA analysis, INTRACRANIAL hemorrhage, IATROGENIC diseases, BRAIN surgery
Abstract

Background: The transmission of amyloid β (Aβ) in humans leading to iatrogenic cerebral amyloid angiopathy (iCAA) is a novel concept with analogies to prion diseases. However, the number of published cases is low, and larger international studies are missing. Aims: We aimed to build a large multinational collaboration on iCAA to better understand the clinical spectrum of affected patients. Methods: We collected clinical data on patients with iCAA from Austria, Croatia, Italy, Slovenia, and Spain. Patients were included if they met the proposed Queen Square diagnostic criteria (QSC) for iCAA. In addition, we pooled data on disease onset, latency, and cerebrospinal fluid (CSF) biomarkers from previously published iCAA cases based on a systematic literature review. Results: Twenty-seven patients (22% women) were included in this study. Of these, 19 (70%) met the criteria for probable and 8 (30%) for possible iCAA. Prior neurosurgical procedures were performed in all patients (93% brain surgery, 7% spinal surgery) at median age of 8 (interquartile range (IQR) = 4–18, range = 0–26 years) years. The median symptom latency was 39 years (IQR = 34–41, range = 28–49). The median age at symptom onset was 49 years (IQR = 43–55, range = 32–70). Twenty-one patients (78%) presented with intracranial hemorrhage and 3 (11%) with seizures. Conclusions: Our large international case series of patients with iCAA confirms a wide age boundary for the diagnosis of iCAA. Dissemination of awareness of this rare condition will help to identify more affected patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

28. The role of clinical and neuroimaging features in the diagnosis of CADASIL

Author

Bersano, Anna, Bedini, Gloria, Markus, Hugh Stephen, Vitali, Paolo, Colli-Tibaldi, Enrico, Taroni, Franco, Gellera, Cinzia, Baratta, Silvia, Mosca, Lorena, Carrera, Paola, Ferrari, Maurizio, Cereda, Cristina, Grieco, Gaetano, Lanfranconi, Silvia, Mazucchelli, Franca, Zarcone, Davide, De Lodovici, Maria Luisa, Bono, Giorgio, Boncoraglio, Giorgio Battista, Parati, Eugenio Agostino, Calloni, Maria Vittoria, Perrone, Patrizia, Bordo, Bianca Maria, Motto, Cristina, Agostoni, Elio, Pezzini, Alessandro, Padovani, Alessandro, Micieli, Giuseppe, Cavallini, Anna, Molini, Graziella, Sasanelli, Francesco, Sessa, Maria, Comi, Giancarlo, Checcarelli, Nicoletta, Carmerlingo, Massimo, Corato, Manuel, Marcheselli, Simona, Fusi, Laura, Grampa, Giampiero, Uccellini, Davide, Beretta, Simone, Ferrarese, Carlo, Incorvaia, Barbara, Tadeo, Carlo Sebastiano, Adobbati, Laura, Silani, Vincenzo, Faragò, Giuseppe, Trobia, Nadia, Grond-Ginsbach, Caspar, Candelise, Livia, and on behalf of Lombardia GENS-group

Published
2018
Full Text
View/download PDF

29. University education and cervical artery dissection

Author

Kellert, Lars, Grau, Armin, Pezzini, Alessandro, Debette, Stéphanie, Leys, Didier, Caso, Valeria, Thijs, Vincent N., Bersano, Anna, Touzé, Emmanuel, Tatlisumak, Turgut, Traenka, Christopher, Lyrer, Philippe A., Engelter, Stefan T., Metso, Tiina M., Grond-Ginsbach, Caspar, Kloss, Manja, and for the Cervical Artery Dissection and Ischemic Stroke Patients (CADISP)-Study Group

Published
2018
Full Text
View/download PDF

30. Proteome Profiling of the Dura Mater in Patients with Moyamoya Angiopathy

Author

Carrozzini, Tatiana, primary, Pollaci, Giuliana, additional, Gorla, Gemma, additional, Potenza, Antonella, additional, Rifino, Nicola, additional, Acerbi, Francesco, additional, Vetrano, Ignazio G., additional, Ferroli, Paolo, additional, Bersano, Anna, additional, Gianazza, Erica, additional, Banfi, Cristina, additional, and Gatti, Laura, additional

Published
2023
Full Text
View/download PDF

31. The diagnostic challenge of Divry van Bogaert and Sneddon Syndrome: Report of three cases and literature review

Author

Bersano, Anna, Morbin, Michela, Ciceri, Elisa, Bedini, Gloria, Berlit, Peter, Herold, Michele, Saccucci, Stefania, Fugnanesi, Valeria, Nordmeyer, Hannes, Faragò, Giuseppe, Savoiardo, Mario, Taroni, Franco, Carriero, MariaRita, Boncoraglio Giorgio, Battista, Perucca, Laura, Caputi, Luigi, Parati Eugenio, Agostino, and Kraemer, Markus

Published
2016
Full Text
View/download PDF

34. Artery occlusion independently predicts unfavorable outcome in cervical artery dissection

Author

Traenka, Christopher, Grond-Ginsbach, Caspar, Goeggel Simonetti, Barbara, Metso, Tiina M., Debette, Stéphanie, Pezzini, Alessandro, Kloss, Manja, Majersik, Jennifer J., Southerland, Andrew M., Leys, Didier, Baumgartner, Ralf, Caso, Valeria, Béjot, Yannick, De Marchis, Gian Marco, Fischer, Urs, Polymeris, Alexandros, Sarikaya, Hakan, Thijs, Vincent, Worrall, Bradford B., Bersano, Anna, Brandt, Tobias, Gensicke, Henrik, Bonati, Leo H., Touzeé, Emmanuel, Martin, Juan J., Chabriat, Hugues, Tatlisumak, Turgut, Arnold, Marcel, Engelter, Stefan T., and Lyrer, Philippe

Published
2020
Full Text
View/download PDF

35. Genetic Imbalance Is Associated With Functional Outcome After Ischemic Stroke

Author

Pfeiffer, Dorothea, Chen, Bowang, Schlicht, Kristina, Ginsbach, Philip, Abboud, Sherine, Bersano, Anna, Bevan, Steve, Brandt, Tobias, Caso, Valeria, Debette, Stéphanie, Erhart, Philipp, Freitag-Wolf, Sandra, Giacalone, Giacomo, Grau, Armin J., Hayani, Eyad, Jern, Christina, Jiménez-Conde, Jordi, Kloss, Manja, Krawczak, Michael, Lee, Jin-Moo, Lemmens, Robin, Leys, Didier, Lichy, Christoph, Maguire, Jane M., Martin, Juan J., Metso, Antti J., Metso, Tiina M., Mitchell, Braxton D., Pezzini, Alessandro, Rosand, Jonathan, Rost, Natalia S., Stenman, Martin, Tatlisumak, Turgut, Thijs, Vincent, Touzé, Emmanuel, Traenka, Christopher, Werner, Inge, Woo, Daniel, Del Zotto, Elisabetta, Engelter, Stefan T., Kittner, Steven J., Cole, John W., Grond-Ginsbach, Caspar, Lyrer, Philippe A., and Lindgren, Arne

Published
2019
Full Text
View/download PDF

37. Quantification of retinal ganglion cell loss in patients with homonymous visual field defect due to stroke

Author

Bianchi Marzoli, S, Melzi, L, Ciasca, P, Raggi, A, Bersano, A, Casati, C, Bolognini, N, Bianchi Marzoli, Stefania, Melzi, Lisa, Ciasca, Paola, Raggi, Alberto, Bersano, Anna, Casati, Carlotta, Bolognini, Nadia, Bianchi Marzoli, S, Melzi, L, Ciasca, P, Raggi, A, Bersano, A, Casati, C, Bolognini, N, Bianchi Marzoli, Stefania, Melzi, Lisa, Ciasca, Paola, Raggi, Alberto, Bersano, Anna, Casati, Carlotta, and Bolognini, Nadia

Abstract

Background: To quantify the degree of ganglion cell degeneration through spectral domain optical coherence tomography (SD-OCT) in adult patients with post-stroke homonymous visual field defect. Methods: Fifty patients with acquired visual field defect due to stroke (mean age = 61 years) and thirty healthy controls (mean age = 58 years) were included. Mean deviation (MD) and pattern standard deviation (PSD), average peripapillary retinal nerve fibre layer thickness (pRNLF-AVG), average ganglion cell complex thickness (GCC-AVG), global loss volume (GLV) and focal loss volume (FLV) were measured. Patients were divided according to the damaged vascular territories (occipital vs. parieto-occipital) and stroke type (ischaemic vs. haemorrhagic). Group analysis was conducted with ANOVA and multiple regressions. Results: pRNFL-AVG was significantly decreased among patients with lesions in parieto-occipital territories compared to controls and to patients with lesions in occipital territories (p =.04), with no differences with respect to stroke type. GCC-AVG, GLV and FLV differed in stroke patients and controls, regardless of stroke type and involved vascular territories. Age and elapsed time from stroke had a significant effect on pRNFL-AVG and GCC-AVG (p <.01), but not on MD and PSD. Conclusions: Reduction of SD-OCT parameters occurs following both ischaemic and haemorrhagic occipital stroke, but it is larger when the injury extends to parietal territories and increases as time since stroke increases. The size of visual field defect is unrelated to SD-OCT measurements. Macular GCC thinning appeared to be more sensitive than pRNFL in detecting retrograde retinal ganglion cell degeneration and its retinotopic pattern in stroke.

Published
2023

38. European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy Endorsed by Vascular European Reference Network (VASCERN)

Author

Bersano, Anna, primary, Khan, Nadia, additional, Fuentes, Blanca, additional, Acerbi, Francesco, additional, Canavero, Isabella, additional, Tournier-Lasserve, Elisabeth, additional, Vajcoczy, Peter, additional, Zedde, Maria Luisa, additional, Hussain, Salman, additional, Lémeret, Sabrina, additional, Kraemer, Markus, additional, and Herve, Dominique, additional

Published
2023
Full Text
View/download PDF

40. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection

Author

Debette, Stéphanie, Compter, Annette, Labeyrie, Marc-Antoine, Uyttenboogaart, Maarten, Metso, Tina M, Majersik, Jennifer J, Goeggel-Simonetti, Barbara, Engelter, Stefan T, Pezzini, Alessandro, Bijlenga, Philippe, Southerland, Andrew M, Naggara, Olivier, Béjot, Yannick, Cole, John W, Ducros, Anne, Giacalone, Giacomo, Schilling, Sabrina, Reiner, Peggy, Sarikaya, Hakan, Welleweerd, Janna C, Kappelle, L Jaap, de Borst, Gert Jan, Bonati, Leo H, Jung, Simon, Thijs, Vincent, Martin, Juan J, Brandt, Tobias, Grond-Ginsbach, Caspar, Kloss, Manja, Mizutani, Tohru, Minematsu, Kazuo, Meschia, James F, Pereira, Vitor M, Bersano, Anna, Touzé, Emmanuel, Lyrer, Philippe A, Leys, Didier, Chabriat, Hugues, Markus, Hugh S, Worrall, Bradford B, Chabrier, Stéphane, Baumgartner, Ralph, Stapf, Christian, Tatlisumak, Turgut, Arnold, Marcel, and Bousser, Marie-Germaine

Published
2015
Full Text
View/download PDF

45. sj-docx-5-eso-10.1177_23969873221144089 – Supplemental material for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)

Author

Bersano, Anna, Khan, Nadia, Fuentes, Blanca, Acerbi, Francesco, Canavero, Isabella, Tournier-Lasserve, Elisabeth, Vajcoczy, Peter, Zedde, Maria Luisa, Hussain, Salman, Lémeret, Sabrina, Kraemer, Markus, and Herve, Dominique

Subjects
FOS: Clinical medicine, Cardiology, Medicine, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-5-eso-10.1177_23969873221144089 for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN) by Anna Bersano, Nadia Khan, Blanca Fuentes, Francesco Acerbi, Isabella Canavero, Elisabeth Tournier-Lasserve, Peter Vajcoczy, Maria Luisa Zedde, Salman Hussain, Sabrina Lémeret, Markus Kraemer and Dominique Herve in European Stroke Journal

Published
2023
Full Text
View/download PDF

46. sj-docx-6-eso-10.1177_23969873221144089 – Supplemental material for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)

Author

Bersano, Anna, Khan, Nadia, Fuentes, Blanca, Acerbi, Francesco, Canavero, Isabella, Tournier-Lasserve, Elisabeth, Vajcoczy, Peter, Zedde, Maria Luisa, Hussain, Salman, Lémeret, Sabrina, Kraemer, Markus, and Herve, Dominique

Subjects
FOS: Clinical medicine, Cardiology, Medicine, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-6-eso-10.1177_23969873221144089 for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN) by Anna Bersano, Nadia Khan, Blanca Fuentes, Francesco Acerbi, Isabella Canavero, Elisabeth Tournier-Lasserve, Peter Vajcoczy, Maria Luisa Zedde, Salman Hussain, Sabrina Lémeret, Markus Kraemer and Dominique Herve in European Stroke Journal

Published
2023
Full Text
View/download PDF

47. sj-docx-2-eso-10.1177_23969873221144089 – Supplemental material for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)

Author

Bersano, Anna, Khan, Nadia, Fuentes, Blanca, Acerbi, Francesco, Canavero, Isabella, Tournier-Lasserve, Elisabeth, Vajcoczy, Peter, Zedde, Maria Luisa, Hussain, Salman, Lémeret, Sabrina, Kraemer, Markus, and Herve, Dominique

Subjects
FOS: Clinical medicine, Cardiology, Medicine, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-2-eso-10.1177_23969873221144089 for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN) by Anna Bersano, Nadia Khan, Blanca Fuentes, Francesco Acerbi, Isabella Canavero, Elisabeth Tournier-Lasserve, Peter Vajcoczy, Maria Luisa Zedde, Salman Hussain, Sabrina Lémeret, Markus Kraemer and Dominique Herve in European Stroke Journal

Published
2023
Full Text
View/download PDF

48. sj-docx-3-eso-10.1177_23969873221144089 – Supplemental material for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)

Author

Bersano, Anna, Khan, Nadia, Fuentes, Blanca, Acerbi, Francesco, Canavero, Isabella, Tournier-Lasserve, Elisabeth, Vajcoczy, Peter, Zedde, Maria Luisa, Hussain, Salman, Lémeret, Sabrina, Kraemer, Markus, and Herve, Dominique

Subjects
FOS: Clinical medicine, Cardiology, Medicine, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-3-eso-10.1177_23969873221144089 for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN) by Anna Bersano, Nadia Khan, Blanca Fuentes, Francesco Acerbi, Isabella Canavero, Elisabeth Tournier-Lasserve, Peter Vajcoczy, Maria Luisa Zedde, Salman Hussain, Sabrina Lémeret, Markus Kraemer and Dominique Herve in European Stroke Journal

Published
2023
Full Text
View/download PDF

49. sj-docx-4-eso-10.1177_23969873221144089 – Supplemental material for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)

Author

Bersano, Anna, Khan, Nadia, Fuentes, Blanca, Acerbi, Francesco, Canavero, Isabella, Tournier-Lasserve, Elisabeth, Vajcoczy, Peter, Zedde, Maria Luisa, Hussain, Salman, Lémeret, Sabrina, Kraemer, Markus, and Herve, Dominique

Subjects
FOS: Clinical medicine, Cardiology, Medicine, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-4-eso-10.1177_23969873221144089 for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN) by Anna Bersano, Nadia Khan, Blanca Fuentes, Francesco Acerbi, Isabella Canavero, Elisabeth Tournier-Lasserve, Peter Vajcoczy, Maria Luisa Zedde, Salman Hussain, Sabrina Lémeret, Markus Kraemer and Dominique Herve in European Stroke Journal

Published
2023
Full Text
View/download PDF

50. sj-docx-1-eso-10.1177_23969873221144089 – Supplemental material for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)

Author

Bersano, Anna, Khan, Nadia, Fuentes, Blanca, Acerbi, Francesco, Canavero, Isabella, Tournier-Lasserve, Elisabeth, Vajcoczy, Peter, Zedde, Maria Luisa, Hussain, Salman, Lémeret, Sabrina, Kraemer, Markus, and Herve, Dominique

Subjects
FOS: Clinical medicine, Cardiology, Medicine, 110904 Neurology and Neuromuscular Diseases
Abstract

Supplemental material, sj-docx-1-eso-10.1177_23969873221144089 for European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN) by Anna Bersano, Nadia Khan, Blanca Fuentes, Francesco Acerbi, Isabella Canavero, Elisabeth Tournier-Lasserve, Peter Vajcoczy, Maria Luisa Zedde, Salman Hussain, Sabrina Lémeret, Markus Kraemer and Dominique Herve in European Stroke Journal

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results